Bariatric surgery: an IDF statement for obese Type 2 diabetes

Abstract

Diabet. Med. 28, 628–642 (2011) The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health experts to review the appropriate role of surgery and other gastrointestinal interventions in the treatment and prevention of Type 2 diabetes. The specific goals were: to develop practical recommendations for clinicians on patient selection; to identify barriers to surgical access and suggest interventions for health policy changes that ensure equitable access to surgery when indicated; and to identify priorities for research. Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type 2 diabetes. It is an effective, safe and cost‐effective therapy for obese Type 2 diabetes. Surgery can be considered an appropriate treatment for people with Type 2 diabetes and obesity not achieving recommended treatment targets with medical therapies, especially in the presence of other major co‐morbidities. The procedures must be performed within accepted guidelines and require appropriate multidisciplinary assessment for the procedure, comprehensive patient education and ongoing care, as well as safe and standardized surgical procedures. National guidelines for bariatric surgery need to be developed for people with Type 2 diabetes and a BMI of 35 kg/m 2 or more.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 81

1. 1.

   Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract. 2010;87:2-3.

   Not in our library10.1016/j.diabres.2009.11.006

2. 2.

   Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.

   Not in our library10.1016/j.diabres.2009.10.007

3. 3.

   Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-880.

   Not in our library10.1038/nature05487

4. 4.

   Kumanyika SK, Obarzanek E, Stettler N, Bell R, Field AE, Fortmann SP, et al. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the Expert Panel on Population and Prevention Science). Circulation. 2008;118:428-464.

   Not in our library10.1161/circulationaha.108.189702

5. 5.

   Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752.

   Not in our library10.1056/nejmoa066254

6. 6.

   Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-256.

   Not in our library10.1016/j.amjmed.2008.09.041

7. 7.

   Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.

   Not in our library10.1056/nejmoa035622

8. 8.

   Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc. 2004;292:1724-1737.

   Not in our library10.1001/jama.292.14.1724

9. 9.

   Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.

   Not in our library10.1056/nejmoa066603

10. 10.

    Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond). 2007;31:569-577.

    Not in our library10.1038/sj.ijo.0803560

11. 11.

    Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14:S1-S83.

    Not in our library10.4158/ep.14.s1.1

12. 12.

    Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. 2006.

    Not in our library

13. 13.

    Lakdawala M, Bhasker A. Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population: 9–10 August 2008, Trivandrum, India. Obes Surg. 2010;20:929-936.

    Not in our library10.1007/s11695-010-0162-7

14. 14.

    Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399-405.

    Not in our library10.1097/sla.0b013e3181be34e7

15. 15.

    Zimmet P, Campbell LV, Toomath R, Twigg S, Wittert G, Proietto J. Bariatric surgery to treat severely obese patientswith type 2 diabetes: a consensus statement. Obes Res Clin Pract. 2011.

    Not in our library10.1016/j.orcp.2010.11.005

16. 16.

    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009;52:17-30.

    Not in our library10.1007/s00125-008-1157-y

17. 17.

    Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-486.

    Not in our library10.7326/0003-4819-122-7-199504010-00001

18. 18.

    Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-969.

    Not in our library10.2337/diacare.17.9.961

19. 19.

    Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med. 2007;45:348-352.

    Not in our library10.1016/j.ypmed.2007.07.020

20. 20.

    Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30:1374-1383.

    Not in our library10.2337/dc07-0048

21. 21.

    Norris SL, Zhang X, Avenell A, Gregg E, Brown TJ, Schmid CH, et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev. 2005;CD004095.

    Not in our library10.1002/14651858.cd004095.pub2

22. 22.

    Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;CD004096.

    Not in our library10.1002/14651858.cd004096.pub2

23. 23.

    Farooqi IS, O'Rahilly S. Genetic factors in human obesity. Obes Rev. 2007;8:S37-S40.

    Not in our library10.1111/j.1467-789x.2007.00315.x

24. 24.

    Swinburn B, Egger G. Prevention of type 2 diabetes. Prevention needs to reduce obesogenic environments. Br Med J. 2001;323:997.

    Not in our library

25. 25.

    Schwartz MW, Porte D. Diabetes, obesity, and the brain. Science. 2005;307:375-379.

    Not in our library10.1126/science.1104344

26. 26.

    Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621-628.

    Not in our library10.1056/nejm199503093321001

27. 27.

    Foo J, Toomath R, Wickremesekera SK, Bann S, Stubbs R. Bariatric surgery: a dilemma for the health system? N Z Med J. 2010;123:12-14.

    Not in our library

28. 28.

    Dixon JB. Referral for a bariatric surgical consultation: it is time to set a standard of care. Obes Surg. 2009;19:641-644.

    Not in our library10.1007/s11695-008-9765-7

29. 29.

    Tripathy D, Chavez AO. Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep. 2010;10:184-191.

    Not in our library10.1007/s11892-010-0115-5

30. 30.

    Overview of 6 years’ therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group, study 16. Diabetes. 1995;44:1249-1258.

    Not in our library

31. 31.

    Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, et al. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care. 2010;33:983-990.

    Not in our library10.2337/dc09-1278

32. 32.

    Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565-1576.

    Not in our library10.1056/nejmoa0806359

33. 33.

    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193-203.

    Not in our library10.2337/dc08-9025

34. 34.

    Trompet S, de Craen AJ, Mooijaart S, Stott DJ, Ford I, Sattar N, et al. High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER Study. Clin Cancer Res. 2009;15:7744-7748.

    Not in our library10.1158/1078-0432.ccr-09-2152

35. 35.

    Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia. 2002;45:S23-S28.

    Not in our library10.1007/s00125-002-0863-0

36. 36.

    Roman G, Hancu N. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes. Horm Metab Res. 2009;41:116-122.

    Not in our library10.1055/s-0028-1128144

37. 37.

    Bailey CJ, Del Prato S, Eddy D, Zinman B. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Int J Clin Pract. 2005;59:1309-1316.

    Not in our library10.1111/j.1742-1241.2005.00675.x

38. 38.

    Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009;CD003641.

    Not in our library10.1002/14651858.cd003641.pub3

39. 39.

    Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25:527-531.

    Not in our library10.1007/s002680020348

40. 40.

    Rubino F, R'Bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol. 2010;6:102-109.

    Not in our library10.1038/nrendo.2009.268

41. 41.

    Laferrere B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479-2485.

    Not in our library10.1210/jc.2007-2851

42. 42.

    Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-350.

    Not in our library10.1097/00000658-199509000-00011

43. 43.

    Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. J Am Med Assoc. 2008;299:316-323.

    Not in our library10.1001/jama.299.3.316

44. 44.

    Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211-2219.

    Not in our library10.1056/nejmoa1000367

45. 45.

    Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-1096.

    Not in our library10.1016/s0140-6736(09)60318-4

46. 46.

    Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10:653-662.

    Not in our library10.1016/s1470-2045(09)70159-7

47. 47.

    Peeters A, O'Brien PE, Laurie C, Anderson M, Wolfe R, Flum D, et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg. 2007;246:1028-1033.

    Not in our library10.1097/sla.0b013e31814a6929

48. 48.

    Kolotkin RL, Crosby RD, Gress RE, Hunt SC, Adams TD. Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls. Surg Obes Relat Dis. 2009;5:250-256.

    Not in our library10.1016/j.soard.2009.01.009

49. 49.

    Dixon JB, Dixon ME, O'Brien PE. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res. 2001;9:713-721.

    Not in our library10.1038/oby.2001.96

50. 50.

    Zhuo X, Zhang P, Hoerger T. Lifetime cost of type 2 diabetes in the US.

    Not in our library

51. 51.
    The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation · 2009

    Not checked
52. 52.

    Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14:589-596.

    Not in our library

53. 53.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

54. 54.

    Baur LA, Fitzgerald DA. Recommendations for bariatric surgery in adolescents in Australia and New Zealand. J Paediatr Child Health. 2010;46:704-707.

    Not in our library10.1111/j.1440-1754.2010.01875.x

55. 55.

    Inge TH, Krebs NF, Garcia VF, Skelton JA, Guice KS, Strauss RS, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114:217-223.

    Not in our library10.1542/peds.114.1.217

56. 56.

    Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549-2557.

    Not in our library10.1056/nejmoa033179

57. 57.

    Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19:1605-1611.

    Not in our library10.1007/s11695-009-0014-5

58. 58.

    Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621-632.

    Not in our library10.1016/j.surg.2007.07.018

59. 59.

    Clinical Practice Guidelines for the Management of Overweight and Obesity in Adults. 2003.

    Not in our library

60. 60.

    Nguyen NT, Hinojosa M, Fayad C, Varela E, Wilson SE. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg. 2007;205:248-255.

    Not in our library10.1016/j.jamcollsurg.2007.03.011

61. 61.

    Encinosa WE, Bernard DM, Du D, Steiner CA. Recent improvements in bariatric surgery outcomes. Med Care. 2009;47:531-535.

    Not in our library10.1097/mlr.0b013e31819434c6

62. 62.

    DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2010;6:347-355.

    Not in our library10.1016/j.soard.2009.11.015

63. 63.

    Standards of medical care in diabetes—2010. Diabetes Care. 2010;33:S11-S61.

    Not in our library10.2337/dc10-s011

64. 64.

    Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med. 2009;150:94-103.

    Not in our library10.7326/0003-4819-150-2-200901200-00007

65. 65.

    Dixon JB, O'Brien P. Health outcomes of severely obese Type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25:358-363.

    Not in our library10.2337/diacare.25.2.358

66. 66.

    Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467-484.

    Not in our library10.1097/01.sla.0000089851.41115.1b

67. 67.

    Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1-11.

    Not in our library10.1097/01.sla.0000102989.54824.fc

68. 68.

    Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 2005;288:E447-E453.

    Not in our library10.1152/ajpendo.00153.2004

69. 69.

    Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-749.

    Not in our library10.1097/01.sla.0000224726.61448.1b

70. 70.

    Geloneze B, Geloneze SR, Fiori C, Stabe C, Tambascia MA, Chaim EA, et al. Surgery for non-obese type 2 diabetic patients: an interventional study with duodenal–jejunal exclusion. Obes Surg. 2009;19:1077-1083.

    Not in our library10.1007/s11695-009-9844-4

71. 71.

    Lee HC, Kim MK, Kwon HS, Kim E, Song KH. Early changes in incretin secretion after laparoscopic duodenal–jejunal bypass surgery in type 2 diabetic patients. Obes Surg. 2010;20:1530-1535.

    Not in our library10.1007/s11695-010-0248-2

72. 72.

    DePaula AL, Stival A, Halpern A, Vencio S. Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI < 35: an analysis of 454 consecutive patients. World J Surg. 2011;35:102-108.

    Not in our library10.1007/s00268-010-0799-3

73. 73.

    Kumar KV, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, et al. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther. 2009;11:785-789.

    Not in our library10.1089/dia.2009.0070

74. 74.

    Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.

    Not in our library10.1016/s0140-6736(03)15268-3

75. 75.

    Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1-253.

    Not in our library

76. 76.

    Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32:567-574.

    Not in our library10.2337/dc08-1749

77. 77.

    Hoerger TJ, Zhang P, Segel JE, Kahn HS, Barker LE, Couper S. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33:1933-1939.

    Not in our library10.2337/dc10-0554

78. 78.

    Gastrointestinal surgery for severe obesity: NIH Consensus Development Conference Statement. Am J Clin Nutr. 1992;55:615S-619S.

    Not in our library10.1093/ajcn/55.2.615s

79. 79.

    Logue J, Thompson L, Romanes F, Wilson DC, Thompson J, Sattar N. Management of obesity: summary of SIGN guideline. Br Med J. 2010;340:c154.

    Not in our library10.1136/bmj.c154

80. 80.

    DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134-140.

    Not in our library10.1016/j.soard.2007.01.005

81. 81.

    Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445-454.

    Not in our library10.1056/nejmoa0901836

Cited by papers we hold 2

• Defining and Predicting Complete Remission of Type 2 Diabetes: A Short-Term Efficacy Study of Open Gastric Bypass · 2013
  Not checked
• Diabetes and Weight in Comparative Studies of Bariatric Surgery vs Conventional Medical Therapy: A Systematic Review and Meta-Analysis · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.